Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Monsanto"


25 mentions found


24. Carbon Robotics
  + stars: | 2024-05-14 | by ( Cnbc.Com Staff | ) www.cnbc.com   time to read: +4 min
In a sign of how the ties between the deepest players in the field of artificial intelligence and other sectors of the economy are growing, Nvidia just announced a venture investment in Carbon Robotics in May. Carbon Robotics is a pioneer in AI-powered agricultural robotics designed to help farmers cut costs, boost production and improve crop yield. In 2023, Carbon Robotics opened two new facilities: Carbon Robotics North and its Richland, Washington-based laser refurbishing and manufacturing facility, allowing the company to increase production rates — it says demand tripled year over year in 2023. Carbon Robotics has also added seven European languages to the LaserWeeder's iPad operator app. To continue its growth, Carbon Robotics raised $43 million in new capital in 2023, just over half of the $80 million it has raised since its founding.
Persons: it's, Paul Mikesell Organizations: Monsanto, Syngenta, BASF, Nvidia, Carbon Robotics, NBC, Deere, Robotics, AndNowUKnow, Stout Industrial Technology, Bear Flag Robotics, Technology Locations: Richland , Washington, Europe, Australia
The idea involves slashing the corporate bureaucracy, giving employees more control, and, hopefully, as a result, allowing the company to innovate efficiently. This story is available exclusively to Business Insider subscribers. "We hire highly educated, trained people, and then we put them in these environments with rules and procedures and eight layers of hierarchy," Anderson said in an interview with Business Insider earlier this year. In a traditional corporate setting, the organizational chart flows upward: Lower-level employees have managers, those managers have managers, and so on until the top of the chain. In comes a key part of Anderson's proposal: Cut a big chunk of the middle managers and let employees choose the projects they want to pursue.
Persons: , Alka, Seltzer, Claritin, Bill Anderson, Anderson, It's, That's, Bayer, Nicholas Bloom, Bloom, — Bloom Organizations: Service, Bayer, Business, Street Journal, Monsanto, Stanford University, American Economic Locations: New Jersey
Bayer calls off break-up to tackle challenges for up to 3 years
  + stars: | 2024-03-05 | by ( ) www.cnbc.com   time to read: +3 min
The Bayer AG logo sits behind silhouetted members of the management board during the company's annual general meeting in Bonn, Germany, May 25, 2018. The cutbacks will reduce annual costs by 2 billion euros from 2026, it added. To shore up its finances, that German drugmaker has slashed dividends, keeping what analysts estimate would have been combined payouts of 6-7 billion euros over three years. Bayer's net debt at the end of 2023 was up 8.5% to 34.5 billion euros. The company said it would seek to reduce net debt by 1-2 billion this year.
Persons: Bayer, Bill Anderson, Anderson, glyphosate Organizations: Bayer AG, Reuters, Monsanto Locations: Bonn, Germany
From The Searle Freedom TrustThis year, the Searle trust is poised to play an even bigger role as it empties out its coffers. Researchers who study political nonprofits say that the Searle trust has had a major impact, even as the Searle family has stayed under the radar compared to more well-known conservative benefactors. The Searle trust is one of the most prolific funders of conservative groups among all private foundations, according to a CNN analysis of nonprofit tax data. The Searle trust has given millions to the Foundation for Government Accountability, which has worked behind the scenes to push conservative policies such as stricter voting laws. Dennis, the CEO of the Searle trust, is also the chair of DonorsTrust.
Persons: Searle, Daniel C, Trump, Donald Trump, , Galen Hall, who’s, Kimberly Dennis, ” Searle, , Sarah Scaife, doesn’t, Michael B, Thomas, SPN, They’ve, ” Brendan Fischer, Brendan Fischer, “ They’ve, ” Hall, Caleb Rossiter, ” Galen Hall, movement’s MAGA, It’s, Mike Pence, that’s, Dennis, Henry Ford, John D, Rockefeller, ” Fischer, Gideon, Michael Searle, ” Dennis, “ We’re, Dan, Gideon Daniel Searle, Daniel Searle, Jonathan Eig, Jack Searle, Daniel Searle’s, Gregory Pincus, John Rock, Pincus, weren’t, , Sue, Eig, Margaret Marsh, Enovid, misoprostol, Searle –, Pfizer –, ” Daniel Searle, Donald Rumsfeld, Searles, Biden, Wade, Dobbs, Kristen Batstone Organizations: CNN, Searle Freedom Trust, University of Michigan, Sarah Scaife Foundation, Searle, American Enterprise Institute, Reason Foundation, Tax Foundation, Manhattan Institute, Cato Institute, Foundation, Government, State Policy Network, American Legislative Exchange Council, Fair, Pacific Legal Foundation, Federalist Society, Competitive Enterprise Institute, Environment Research Center, CO2 Coalition, Heartland Institute, , CO2, Heartland, Republican Party, movement’s, America, Policy Institute, Trump, American Freedom Foundation, Everett, FDA, Rutgers University, Pfizer, Monsanto, Heritage Foundation, Reason, Affordable, New Civil Liberties Alliance, Public Policy Center, Claremont, National Women’s Health Network, Trust, IRS Locations: Missouri, St, Louis , Missouri, California, judgeships, , Omaha, Metamucil, Dramamine, Puerto, Brazil, Diet Coke, America
Berkshire Hathaway continued to buy Liberty Media's tracking stock for New York-based satellite radio company SiriusXM in a likely merger arbitrage play. Billionaire John Malone's media conglomerate currently owns 84% of Sirius XM and has two tracking stocks that represent that stake in the streaming satellite music service — Liberty Media Corp. Series A shares, or LSXMA , and Liberty Media Corp. Series C shares, or LSXMK . Under the terms of the deal, expected to close early in the third quarter, each Liberty Media Sirius tracking share will be exchanged for 8.4 "new" SIRI shares, while "old" SIRI shareholders would receive new shares in a one-for-one exchange. Berkshire loading up In the past week, Warren Buffett's conglomerate added 438,945 shares of LSXMA and 1 million shares of LSXMK for nearly $45 million combined, according to regulatory filings . Berkshire first bought LSXMK in 2016 and now owns almost 22% of the tracking stock, according to FactSet.
Persons: Berkshire Hathaway, John, SIRI, Warren, Buffett, Ted Weschler, Todd Combs, Seth Klarman's Baupost, SIRI overvalued, Wells, Steven Cahall, Cahall, Jason Bazinet, Charlie Munger, Charlie, hasn't Organizations: Berkshire, Liberty, Sirius XM, — Liberty Media Corp, Liberty Media Corp, Nasdaq, Liberty Media, Liberty Media Sirius, Sirius XM Holdings, Sirius, Citigroup, Activision Blizzard, British Columbia Power, Monsanto, Bayer AG, IBM Locations: New York, Berkshire, LSXMA, LSXMK, Omaha
Those losses ended a nine-trial winning streak for Bayer, shattering investor and company hopes that the worst of the Roundup litigation was over. Her case will help test whether plaintiffs' recent victories were an aberration, or the payoff from favorable court rulings and a shift in plaintiffs' strategy. Plaintiffs' lawyers reject the notion that the evidence about regulators explains their wins. While plaintiffs' lawyers in earlier trials mentioned other chemicals, transcripts of recent closing arguments suggest they have become more prominent. More Roundup trials are expected in 2024.
Persons: Wolfgang Rattay, Kelly Martel, Bayer, Martel, glyphosate, That's, Tom Kline, Jason Itkin, Ernest Caranci, Bart Rankin, Rankin, Brendan Pierson, Alexia Garamfalvi, Bill Berkrot Organizations: Bayer AG, REUTERS, Bayer, U.S, Monsanto, . Environmental Protection Agency, EPA, Union, Health, Thomson Locations: Wuppertal, Germany, Philadelphia, Pleas, Pennsylvania, Europe, New York
Bayer CEO Bill Anderson is contending with his predecessor’s disastrous Monsanto acquisition and the need to re-energize Bayer’s drug pipeline. Photo: Krisztian Bocsi/Bloomberg NewsBERLIN— Bayer Chief Executive Bill Anderson said the company would bounce back quickly from a recent spate of bad news, and warned that a breakup of the pharmaceutical and agricultural company was no universal cure for its ailments. A stream of negative news has rekindled calls from investors for Bayer to unlock value by spinning off its units into separate businesses. But in an interview with The Wall Street Journal this week, Anderson said the company couldn’t be distracted from the tough restructuring to fix the businesses.
Persons: Bill Anderson, Krisztian Bocsi, Anderson Organizations: Bloomberg, BERLIN — Bayer, Bayer, Wall
REUTERS/Wolfgang Rattay/File Photo Acquire Licensing RightsNov 21 (Reuters) - A U.S. jury has ordered Bayer's Monsanto to pay $165 million to employees of a school northeast of Seattle who claimed chemicals made by the company called polychlorinated biphenyls, or PCBs, leaked from light fixtures and got them sick. The award included nearly $50 million in compensatory damages, and $115 million in punitive damages. Monsanto said in a statement that it will contest Monday's verdict, and that blood, air and other tests show the school employees were not exposed to unsafe levels of PCBs. PCBs are chemicals once widely used to insulate electrical equipment and in other common products like carbon copy paper, caulking, floor finish and paint. Employees, students and others have claimed in numerous lawsuits against the company that exposure to PCBs at the Sky Valley center caused their cancers, thyroid conditions and other health problems.
Persons: Wolfgang Rattay, Monsanto, Clark Mindock, Alexia Garamfalvi, Richard Chang Organizations: Bayer AG, REUTERS, Monsanto, Sky Valley Education, Thomson Locations: Leverkusen, Germany, U.S, Seattle, Washington, Sky, Monroe , Washington
Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. Each was diagnosed with non-Hodgkin lymphoma that they alleged was caused by using Roundup on their family property. Bayer has said that decades of studies have shown Roundup and its active ingredient, glyphosate, are safe for human use. The verdict is the fourth straight loss in court for Bayer, after the company had been found not liable to plaintiffs in nine consecutive trials. In 2020, Bayer settled most of the then-pending Roundup cases for up to $10.9 billion.
Persons: Wolfgang Rattay, Bayer, Valorie Gunther, Jimmy Draeger of, Daniel Anderson of, Draeger's, Brenda, Bart Rankin, Forrest Weldon, Tom Hals, Bill Berkrot Organizations: Bayer AG, REUTERS, Bayer, Monsanto, Union Investment, U.S . Environmental Protection Agency, EU Commission, European Food Agency, European Chemicals Agency, Thomson Locations: Leverkusen, Germany, Missouri, Cole County , Missouri, New York, Jimmy Draeger of Missouri, Daniel Anderson of California, Wilmington , Delaware
BRUSSELS (AP) — The European Commission will continue the use of the controversial chemical herbicide glyphosate in the European Union for 10 more years after the 27 member countries again failed to find a common position for or against a prolongation. The Greens political group of the EU Parliament immediately urged the Commission to backpedal and ban the use of glyphosate. The 10-year extension proposed by the European Commission required a “qualified majority,” defined as 55% of the 27 members representing at least 65% of the total EU population of some 450 million people. Pascal Canfin, the chair of the Environment committee at the European Parliament, blamed the EU Commission president for moving forward despite the stalemate. EU member states are responsible for authorizing the use of products in their national markets, following a safety evaluation.
Persons: unconclusive, , Bas Eickhout, unfiled, , Pascal Canfin, Ursula von der Leyen, Emmanuel Macron Organizations: European Commission, European Union, Greens, EU, Environment, Monsanto, Bayer, Agency for Research, Cancer, World Health Organization, Environmental Protection Agency, Greenpeace Locations: BRUSSELS, backpedal, California, France, U.S, Germany, Italy
California Jury Awards $332 Million to Man Who Blamed His Cancer on Use of Monsanto WeedkillerA California jury has awarded $332 million to a man who sued chemical giant Monsanto, claiming his cancer was related to decades of using its Roundup weedkiller
Organizations: Monsanto Locations: Monsanto Weedkiller, California
Post-it maker 3M is in danger of coming unstuck
  + stars: | 2023-07-19 | by ( Jeffrey Goldfarb | ) www.reuters.com   time to read: +10 min
There will be up to $1.5 billion of costs related to separating the health care business, 3M has said. Its interest cover, after backing out estimated operating income from health care, would fall to about 4 times from 11 times. And its net debt, using all these assumptions and excluding the health care division, would swell to nearly 5 times EBITDA from less than 2 times. Back out $2.5 billion from health care, as estimated by the Morgan Stanley team, and $1.5 billion of capital expenditure costs noted by Wolfe Research. For example, the water settlement, as drafted, only envisions $4.6 billion of outlays through 2025, and the rest over the ensuing 11 years.
Persons: Mike Roman, Roman, Sackler, Johnson, Aearo, , Morgan Stanley, Smith, Nephew, Lauren Silva Laughlin, Streisand Neto Organizations: YORK, Reuters, U.S . Environmental, Purdue Pharma’s, Association of Metropolitan Water Agencies, Bayer, Monsanto, Aearo Technologies, Partners, Honeywell International, Siemens, 3M, Refinitiv, Reuters Graphics, Wolfe Research, Thomson Locations: . Oregon, Republic, Corning
Bayer crop spinoff would be tricky but bountiful
  + stars: | 2023-07-10 | by ( ) www.reuters.com   time to read: +2 min
LONDON, July 10 (Reuters Breakingviews) - Bayer’s (BAYGn.DE) new CEO may be considering some valuable crop rotation. The 49 billion euro seed-to-drug maker’s shares rallied 3% on Monday after a Friday report by German news service Platow Brief said the company may spin off its troubled crop science division. The crop science division was born of Bayer’s disastrous takeover of Monsanto in 2018, and the German conglomerate is still grappling with lawsuits alleging that its weedkiller caused cancer. If it offloads the crop science division, Bayer could indemnify the new owners against the cost of future litigation up to a certain point. Currently, the crop science division throws off a lot of the combined company’s cash.
Persons: maker’s, Bill Anderson, Bayer, Anderson, Aimee Donnellan, Liam Proud, Pranav Kiran Organizations: Reuters, Monsanto, Twitter, Thames, Thomson Locations: China
REUTERS/Amit Dave/File PhotoNEW DELHI, July 8 (Reuters) - An Indian court rejected PepsiCo Inc's appeal against an order that revoked a patent for a potato variety grown exclusively for the New York-based company's popular Lay's potato chips. The authority removed PepsiCo's patent cover after Kavitha Kuruganti, a farmers' rights activist, argued that the company cannot claim a patent over a seed variety. PepsiCo petitioned the Delhi High Court against the revocation of the patent cover. In its order dated July 5, Delhi High Court judge Navin Chawla dismissed PepsiCo's appeal against the authority's decision. In 2019, PepsiCo sued some Indian farmers for cultivating the FC5 potato variety, accusing growers of infringing its patent.
Persons: Amit Dave, Kavitha Kuruganti, Navin Chawla, Kuruganti, Mayank Bhardwaj, Sumit Khanna, Kim Coghill Organizations: REUTERS, PepsiCo, New, ' Rights, Authority, Court, Monsanto, drugmaker Bayer AG, Thomson Locations: Ahmedabad, India, DELHI, New York, Delhi, PepsiCo India, U.S
His parents soon started exploring a lawsuit against Merck, the developer of the blockbuster asthma and allergy drug, Singulair, along with the manufacturer of the generic version their son took. That meant Merck had written the warning label, with federal approval, on the generic version of Singulair that Nicholas England took. But his parents couldn’t sue Merck, either, because their son had never taken its name-brand version of Singulair. The generic drug manufacturer that made the pills England took, Teva Pharmaceuticals, did not respond to inquiries. Since Merck’s patent on Singulair expired in 2012, major generic drug manufacturers have sold millions of prescriptions under the drug’s scientific name, montelukast.
Persons: Nicholas England, Nicholas, Merck, , Jennifer England, Nicholas’s, ” Merck, Organon, , George W, Bush, Daniel Troy, Troy, Medtronic, Nicholas England’s, Adam Zimmerman, ” Zimmerman, Jay Lefkowitz, Ellis, shouldn’t, Bayer, drugmaker Wyeth, Phenegran, Jan Gilpin’s, mumbling, ” Gilpin, ” “, hadn’t, Singulair, Gilpin, Stephane Bissonnette, suicidality, Dr, Judith Kramer, Duke, Robert England, Robert said, Kim Beck Organizations: Merck, U.S, Teva Pharmaceuticals, Reuters, U.S . Food, Drug Administration, FDA, Big, Corporate America, Corporations, Administration, , New, University of Southern California’s Gould School of Law, Norfolk, Union Pacific, Federal Railroad Safety, Pacific, GlaxoSmithKline, Monsanto, Bayer, Parent Locations: Virginia, England, U.S, New York, Kirkland, East Palestine , Ohio, Louisiana, Atlanta, Vermont, Wise , Virginia, Wisconsin
"Extending the Science and Technology Agreement between the U.S. and China would only further jeopardize our research and intellectual property," said Representative Mike Gallagher, the Republican chair of a congressional select committee on China. "The administration must let this outdated agreement expire." "It is hoped that the U.S. side will expedite the internal review before the expiration of the agreement," he said. Given the state of U.S.-China ties, trying to renegotiate could derail the agreement, they said. Proponents of renewing the deal argue that without it, the U.S. would lose valuable insight into China's technical advances.
Persons: Florence Lo, Antony Blinken, Mike Gallagher, Liu Pengyu, Joe Biden, Kurt Campbell, Denis Simon, Anna Puglisi, Michael Martina, Don Durfee, William Mallard Organizations: REUTERS, WASHINGTON, ., China Science, Technology, Science, U.S, State Department, National Security Council, Hudson Institute, University of North, Chapel Hill, Georgetown University's Center for Security, Emerging Technology, Thomson Locations: China, U.S, United States, Beijing, Washington, Pacific, University of North Carolina, East Asia
Companies Bayer AG FollowNEW YORK, June 15 (Reuters) - Bayer AG (BAYGn.DE) has reached a $6.9 million settlement with New York for allegedly making false and misleading claims regarding the safety of Roundup weedkillers, the state's Attorney General Letitia James said on Thursday. The settlement also requires Bayer and its Monsanto unit to stop advertising that claims Roundup products containing glyphosate are safe and non-toxic. Reporting by Jonathan Stempel in New YorkOur Standards: The Thomson Reuters Trust Principles.
Persons: Letitia James, Jonathan Stempel Organizations: Bayer, Bayer AG, Monsanto, Thomson Locations: New York
Companies Bayer AG FollowNEW YORK, June 15 (Reuters) - Bayer AG (BAYGn.DE) agreed on Thursday to pay $6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup weedkiller as safe. The settlement resolves accusations that Bayer and its Monsanto unit failed to substantiate their repeated claims about Roundup products containing the active ingredient glyphosate. These claims included that Roundup "won't harm anything but weeds," and "do not pose a threat to the health of animal wildlife." James said Bayer's and Monsanto's advertising violated state laws against false and misleading advertising, and breached Monsanto's 1996 settlement with New York over its advertising of Roundup at the time. The settlement requires Bayer and Monsanto to stop advertising that glyphosate-based Roundup is safe and non-toxic.
Persons: Letitia James, Bayer, James, Bayer's, Jonathan Stempel, Chizu Organizations: Bayer, Bayer AG, New York, Monsanto, Thomson Locations: New York
Critics have said such awards encourage frivolous lawsuits and excessive fees going to class action attorneys who may seek to benefit their own interests instead. The Supreme Court in 2019 sidestepped resolving a challenge to cy pres awards in a case involving Google. Conservative Justice Clarence Thomas, dissenting in that case, called cy pres settlements "unfair and unreasonable." Monsanto has called the group, which advocates against what it considers abusive class action procedures, a "serial objector to class-action settlements." The group said in court papers that further steps could have taken to distribute the settlement award to class members.
Bill Anderson joined Bayer’s management board this week and starts as CEO in June. LEVERKUSEN, Germany— Bill Anderson , the American picked to head Bayer AG, treads softly as he begins a monthslong transition into his role as chief executive officer of the German owner of Monsanto, saying he will take his time before trying to fix the company’s most pressing problems. Mr. Anderson, a sprite, athletic 56-year-old hailing from the Gulf coast of Texas, this week joined the management board of Bayer, the 160-year-old chemical and pharmaceutical company known for inventing aspirin more than a century ago. He starts as CEO in June.
Bill Anderson joined Bayer’s management board this week and starts as CEO in June. LEVERKUSEN, Germany— Bill Anderson , the American picked to head Bayer AG, treads softly as he begins a monthslong transition into his role as chief executive officer of the German owner of Monsanto, saying he will take his time before trying to fix the company’s most pressing problems. Mr. Anderson, a sprite, athletic 56-year-old hailing from the Gulf coast of Texas, this week joined the management board of Bayer, the 160-year-old chemical and pharmaceutical company known for inventing aspirin more than a century ago. He starts as CEO in June.
REUTERS/Tom KaeckenhoffLEVERKUSEN, Germany, April 5 (Reuters) - Incoming Bayer (BAYGn.DE) chief executive Bill Anderson says he is keeping an open mind on whether to break up the company into smaller pieces, as some fidgety investors want. "That's why I said I am going to have an open mind," he said. On the stock market Bayer, once the most valuable company on Germany's DAX blue-chip index, is now worth only about the same as it paid for Monsanto. At Bayer, he said he did not have his own desk and made use of the company's meeting rooms as needed. Professing a love of American football, hiking and snowboarding, he was also effusive about Bayer as a company and its heritage of medicines such as Aspirin.
REUTERS/Andrew KellyApril 3 (Reuters) - A Delaware judge on Monday dismissed Merck & Co's (MRK.N) lawsuit seeking to hold Bayer AG (BAYGn.DE) responsible for more talc-related liabilities stemming from its $14.2 billion purchase of Merck's consumer care business in 2014. Bayer welcomed the decision, saying that it expected Merck to "take full responsibility for the product claims". "Bayer will continue to defend itself against any further efforts by Merck to avoid or improperly transfer its liabilities to Bayer," the company said in a statement. The $14.2 billion purchase also included Merck's Claritin allergy medicine and Coppertone sunscreen lines. The case is Merck & Co v. Bayer AG, Delaware Chancery Court, No.
REUTERS/Nick Carey/File PhotoWASHINGTON, March 6 (Reuters) - Several federal agencies will work together on competition issues in the seed sector as part of a broader Biden administration push to enhance competition in agriculture, the U.S. Department of Agriculture (USDA) announced Monday. The USDA, Patent and Trademark Office, Department of Justice, and Federal Trade Commission will start up a working group on intellectual property and competition in the seed and agricultural input sector, USDA said. USDA is also creating a "farmer seed liaison" role to deliver on recommendations in a report released by the agency today on how to promote competition in the seed industry. USDA issued a $73 million round of funding under the same program last fall. Reporting by Leah Douglas in Washington and Karl Plume in Chicago Editing by Nick Zieminski and Sharon SingletonOur Standards: The Thomson Reuters Trust Principles.
But genetically modified wheat has never been grown for commercial purposes due to consumer fears that allergens or toxicities could emerge in a staple used worldwide for bread, pasta and pastries. Australia grows and exports GM cotton and canola, and the country in May approved Bioceres’ biotech wheat for use in foods. Mexico, among the largest buyers of U.S. corn, has said it will halt GM corn imports for human consumption, but walked back a deadline to ban the corn for animal feed. Recent disruptions to global wheat supplies have brought a new degree of urgency to the debate over biotech wheat. Wheat Associates and the National Association of Wheat Growers, support “the eventual commercialization” of biotech wheat, according to their websites, provided that plans are implemented to minimize market disruptions.
Total: 25